Verification of atrial fibrillation treatment in Japan through cost-effectiveness analysis and construction of optimal treatment strategy

2022 Fiscal Year Final Research Report

• Project/Area Number: 20K23226
• Research Category: Grant-in-Aid for Research Activity Start-up
• Allocation Type: Multi-year Fund
• Review Section: 0908:Society medicine, nursing, and related fields
• Research Institution: Ehime University
• Principal Investigator: Kawakami Hiroshi 愛媛大学, 医学部附属病院, 助教 (10771579)
• Project Period (FY): 2020-09-11 – 2023-03-31
• Keywords: 費用対効果分析 / 心房細動 / 睡眠時無呼吸症候群

Outline of Final Research Achievements

With the aging of society in Japan, the number of patients with atrial fibrillation (AF) has been increasing every year. AF can lead to heart failure and stroke, which can cause bedridden, resulting in a significant impact on Japan's healthcare economy due to the associated medical costs. Therefore, in this study, we systematically reviewed literature related to AF treatment and conducted cost-effectiveness analyses for various AF patients based on the results, in order to verify the most cost-effective AF treatment in Japan. As a result of the study, it was revealed that screening and treatment intervention for sleep apnea in patients with AF is highly cost-effective.

Free Research Field

費用対効果分析

Academic Significance and Societal Importance of the Research Achievements

心房細動治療において、睡眠時無呼吸症候群のスクリーニングおよび治療の重要性を明らかにした。心房細動患者において、睡眠時無呼吸症候群は再発リスクの一つである。積極的にスクリーニングを行い、適切な治療介入を行うことで、心房細動治療成績が向上し、最終的には費用対効果に優れた治療戦略となりうることを報告した。本邦の医療費抑制や医療の効率化に寄与する結果と考える。